Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mirjolet

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 31, 2021
[Abscopal effect: Myth or reality?]C Mirjolet, G Truc
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 6, 2023
Radiation-activated nanoparticles: Which combination to optimize radiosensitization?S Penninckx, P Martinive, C Mirjolet
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 4, 2016
Correlation between radio-induced lymphocyte apoptosis measurements obtained from two French centresC Mirjolet, J L Merlin, C Dalban, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 10, 2013
[The role of whole brain radiotherapy with hippocampal-sparing]G Truc, É Martin, C Mirjolet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 4, 2013
[Reirradiations of head and neck cancers: state of the concept and ways of development]B Soltys, N Wiazzane, C Mirjolet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2013
The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-conceptC Mirjolet, A L Papa, G Créhange, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 8, 2016
[Sarcoma developed in irradiated area: Preliminary results of the SARI trial]P Maingon, C Mirjolet, I Diallo, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 28, 2016
A phase I dose escalation study using simultaneous integrated-boost IMRT with temozolomide in patients with unifocal glioblastomaG Truc, V Bernier, C Mirjolet, et al.
Oncoimmunology|February 6, 2018
Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC studyC Mirjolet, C Charon-Barra, S Ladoire, et al.
Clinical and Translational Radiation Oncology|August 15, 2020
<i>In-vivo</i> and <i>in-vitro</i> impact of high-dose rate radiotherapy using flattening-filter-free beams on the anti-tumor immune responseP A Laurent, A Kownacka, R Boidot, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 31, 2021
[Abscopal effect: Myth or reality?]C Mirjolet, G Truc
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 6, 2023
Radiation-activated nanoparticles: Which combination to optimize radiosensitization?S Penninckx, P Martinive, C Mirjolet
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 4, 2016
Correlation between radio-induced lymphocyte apoptosis measurements obtained from two French centresC Mirjolet, J L Merlin, C Dalban, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 10, 2013
[The role of whole brain radiotherapy with hippocampal-sparing]G Truc, É Martin, C Mirjolet, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 4, 2013
[Reirradiations of head and neck cancers: state of the concept and ways of development]B Soltys, N Wiazzane, C Mirjolet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 8, 2013
The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-conceptC Mirjolet, A L Papa, G Créhange, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 8, 2016
[Sarcoma developed in irradiated area: Preliminary results of the SARI trial]P Maingon, C Mirjolet, I Diallo, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 28, 2016
A phase I dose escalation study using simultaneous integrated-boost IMRT with temozolomide in patients with unifocal glioblastomaG Truc, V Bernier, C Mirjolet, et al.
Oncoimmunology|February 6, 2018
Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC studyC Mirjolet, C Charon-Barra, S Ladoire, et al.
Clinical and Translational Radiation Oncology|August 15, 2020
<i>In-vivo</i> and <i>in-vitro</i> impact of high-dose rate radiotherapy using flattening-filter-free beams on the anti-tumor immune responseP A Laurent, A Kownacka, R Boidot, et al.
Pageof 2